• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于土槿皮菌素 A 的侧链衍生物的合成与抗菌评价。

Synthesis and Antimicrobial Evaluation of Side-Chain Derivatives based on Eurotiumide A.

机构信息

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Department of Microbiology and Infection Control Sciences, Kyoto Pharmaceutical University, Misasaginakauchi-cho, Yamashita-Ku, Kyoto 607-8414, Japan.

出版信息

Mar Drugs. 2020 Jan 30;18(2):92. doi: 10.3390/md18020092.

DOI:10.3390/md18020092
PMID:32019233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7074549/
Abstract

Side-chain derivatives of eurotiumide A, a dihydroisochroman-type natural product, have been synthesized and their antimicrobial activities described. Sixteen derivatives were synthesized from a key intermediate of the total synthesis of eurotiumide A, and their antimicrobial activities against two Gram-positive bacteria, methicillin-susceptible and methicillin-resistant (MSSA and MRSA), and a Gram-negative bacterium, , were evaluated. The results showed that derivatives having an iodine atom on their aromatic ring instead of the prenyl moiety displayed better antimicrobial activity than eurotiumide A against MSSA and . Moreover, we discovered that a derivative with an isopentyl side chain, which is a hydrogenated product of eurotiumide A, is the strongest antimicrobial agent against all three strains, including MRSA.

摘要

已合成了青霉胺 A 的侧链衍生物,这是一种二氢异苯并呋喃型天然产物,并描述了它们的抗菌活性。从青霉胺 A 全合成的关键中间体合成了 16 种衍生物,并评估了它们对两种革兰氏阳性菌(耐甲氧西林金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌)和一种革兰氏阴性菌(铜绿假单胞菌)的抗菌活性。结果表明,与青霉胺 A 相比,具有芳环上碘原子而不是prenyl 部分的衍生物对 MSSA 和 显示出更好的抗菌活性。此外,我们发现一种具有异戊基侧链的衍生物,它是青霉胺 A 的氢化产物,是对包括耐甲氧西林金黄色葡萄球菌在内的所有三种菌株具有最强抗菌活性的物质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/2be44e318df0/marinedrugs-18-00092-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/ab2de4960330/marinedrugs-18-00092-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/f711ac6902d3/marinedrugs-18-00092-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/6d4cf2fafd57/marinedrugs-18-00092-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/45f31033fd73/marinedrugs-18-00092-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/e5644452f399/marinedrugs-18-00092-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/f01b3abf63a9/marinedrugs-18-00092-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/2be44e318df0/marinedrugs-18-00092-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/ab2de4960330/marinedrugs-18-00092-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/f711ac6902d3/marinedrugs-18-00092-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/6d4cf2fafd57/marinedrugs-18-00092-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/45f31033fd73/marinedrugs-18-00092-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/e5644452f399/marinedrugs-18-00092-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/f01b3abf63a9/marinedrugs-18-00092-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2417/7074549/2be44e318df0/marinedrugs-18-00092-g003.jpg

相似文献

1
Synthesis and Antimicrobial Evaluation of Side-Chain Derivatives based on Eurotiumide A.基于土槿皮菌素 A 的侧链衍生物的合成与抗菌评价。
Mar Drugs. 2020 Jan 30;18(2):92. doi: 10.3390/md18020092.
2
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).海洋吡咯衍生物作为潜在的抗耐甲氧西林金黄色葡萄球菌抗生素(II)。
Mar Drugs. 2013 Aug 15;11(8):2927-48. doi: 10.3390/md11082927.
3
Synergy of aminoglycoside antibiotics by 3-Benzylchroman derivatives from the Chinese drug Caesalpinia sappan against clinical methicillin-resistant Staphylococcus aureus (MRSA).来自中国药物苏木的3-苄基色满衍生物对临床耐甲氧西林金黄色葡萄球菌(MRSA)的氨基糖苷类抗生素协同作用。
Phytomedicine. 2014 Jun 15;21(7):936-41. doi: 10.1016/j.phymed.2014.03.004. Epub 2014 Apr 2.
4
In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.瑞他帕林对利奈唑胺和耐甲氧西林金黄色葡萄球菌分离株的体外活性。
Rev Esp Quimioter. 2011 Sep;24(3):127-30.
5
Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.具有巯基乙胺连接基的截短侧耳素衍生物的合成及其对耐甲氧西林金黄色葡萄球菌的抗菌活性
Med Chem. 2018;14(6):585-594. doi: 10.2174/1573406414666180416131737.
6
[Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].[通过表型和基因型方法对临床分离金黄色葡萄球菌菌株中大环内酯类、林可酰胺类及链阳菌素B耐药性的研究]
Mikrobiyol Bul. 2015 Jan;49(1):1-14.
7
Susceptibility difference between methicillin-susceptible and methicillin-resistant Staphylococcus aureus to a bovine myeloid antimicrobial peptide (BMAP-28).耐甲氧西林金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌对牛髓源抗菌肽(BMAP-28)的敏感性差异。
Anim Sci J. 2014 Feb;85(2):174-9. doi: 10.1111/asj.12098. Epub 2013 Aug 1.
8
Phenotypic and genotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) from different sources in China.中国不同来源耐甲氧西林金黄色葡萄球菌(MRSA)和甲氧西林敏感金黄色葡萄球菌(MSSA)的表型和基因型特征。
Foodborne Pathog Dis. 2013 Mar;10(3):214-21. doi: 10.1089/fpd.2012.1205. Epub 2013 Feb 13.
9
Muraminomicins, novel ester derivatives: in vitro and in vivo antistaphylococcal activity.穆拉米霉素酯衍生物,新型酯类衍生物:体外和体内抗葡萄球菌活性。
J Antibiot (Tokyo). 2019 Dec;72(12):956-969. doi: 10.1038/s41429-019-0235-3. Epub 2019 Sep 27.
10
Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms.查耳酮类化合物的设计、合成及抗 MSSA 和 MRSA 浮游细胞和生物膜的活性。
Bioorg Chem. 2021 Nov;116:105279. doi: 10.1016/j.bioorg.2021.105279. Epub 2021 Aug 31.

本文引用的文献

1
Asymmetric Total Syntheses and Structure Elucidations of (+)-Eurotiumide F and (+)-Eurotiumide G.(+)-曲霉酰胺F和(+)-曲霉酰胺G的不对称全合成及结构解析
Chem Pharm Bull (Tokyo). 2019;67(9):953-958. doi: 10.1248/cpb.c18-00948.
2
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.天然产物启发的项目在解决抗生素耐药性和耐受性方面的最新进展。
J Med Chem. 2019 Sep 12;62(17):7618-7642. doi: 10.1021/acs.jmedchem.9b00370. Epub 2019 Apr 18.
3
Antimicrobial resistance mechanisms and potential synthetic treatments.
抗菌耐药机制与潜在的合成治疗方法。
Future Sci OA. 2018 Feb 5;4(4):FSO290. doi: 10.4155/fsoa-2017-0109. eCollection 2018 Apr.
4
Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.革兰氏阴性菌来源的抗生素:全面概述及部分生物合成亮点。
Nat Prod Rep. 2017 Jul 1;34(7):712-783. doi: 10.1039/c7np00010c. Epub 2017 Jun 26.
5
Antibacterial Compounds from Marine Bacteria, 2010-2015.2010 - 2015年海洋细菌产生的抗菌化合物
J Nat Prod. 2017 Apr 28;80(4):1215-1228. doi: 10.1021/acs.jnatprod.6b00235. Epub 2017 Mar 31.
6
The microbiota of the respiratory tract: gatekeeper to respiratory health.呼吸道微生物群:呼吸道健康的守护者。
Nat Rev Microbiol. 2017 May;15(5):259-270. doi: 10.1038/nrmicro.2017.14. Epub 2017 Mar 20.
7
The Human Intestinal Microbiome in Health and Disease.健康与疾病中的人类肠道微生物群
N Engl J Med. 2016 Dec 15;375(24):2369-2379. doi: 10.1056/NEJMra1600266.
8
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.抗生素引起的肠道微生物群变化与疾病
Trends Mol Med. 2016 Jun;22(6):458-478. doi: 10.1016/j.molmed.2016.04.003. Epub 2016 May 10.
9
Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances.抗生素与人类肠道微生物群:生态失调与耐药性积累
Front Microbiol. 2016 Jan 12;6:1543. doi: 10.3389/fmicb.2015.01543. eCollection 2015.
10
Antibacterial drug discovery in the resistance era.耐药时代的抗菌药物发现。
Nature. 2016 Jan 21;529(7586):336-43. doi: 10.1038/nature17042.